Myosychiatry – A health killer with an elderly sleeper.
Older people are slow, tired and prone to falling, and many often think that it’s normal to be old, but it’s probably a symptom of disease: myosis — an easy-to-neglect health killer! Let’s get this straight.
What’s myopathy? Meusculosis is muscle reduction, defined as a reduction in muscle weight associated with age growth, accompanied by a reduction in muscle strength and/or body function. In October 2016, myoemia was officially included in the ICD-10 disease code of the International Classification of Diseases as a disease with an independent characteristic. The higher the age, the higher the incidence and the greater the extent of myoemia. In the case of women, muscle strength will decline at a rate of 12 to 15 per cent every 10 years after age 50, and by age 65 it will decrease by 33 to 35 per cent.
Meusculosis is one of the most common syndromes of tumour patients and interacts with anti-tumour treatment. Thus, older oncologists need to pay special attention to the development of musculosis.
2. What are the causes and hazards of myocardia?
The common cause of myusculosemia is pre-histomosis among older persons associated with ageing, as well as other diseases, including tumors, and secondary musculosis caused by severe malnutrition. Inhibited and easily neglected; but if sick, it will seriously damage the health and quality of life of older persons, leading to functional impairment of older persons, increasing the risk of fall, incapacitation and death, as well as the risk of side effects associated with tumour treatment, significantly increasing the care burden on families and medical expenses.
3. How to diagnose myopathy?
It can be diagnosed with reduced muscle + reduced muscle power (shield) or reduced muscle function (normal speed). Simple initial screening and assessment can be carried out by measuring the calves, holding the force, etc. Biotemporal resistance analysis is an internationally accepted method of detection of myocardia diagnosis; a multi-point exposure electrodes, multi-frequency specialized medical instrument, human composition analyser, which uses biotemporal resistance analysis to detect musculoskeletal mass for myocardia diagnosis, has the advantage of being simple and professional.
4. The point is, how can older persons prevent and intervene in myopathy?
(1) Increased physical exercise. Physical exercise, especially resistance, is the most widely recognized and effective means of combating myopathy, which improves the quality of life of older persons, improves their physical functioning and reduces the risk of fall and failure. Sports training programmes should be developed by professional doctors on the basis of a comprehensive assessment of the age of the disease. Set reasonable training targets and achieve greater efficiency and security for the purpose of muscle reinforcement.
(2) Increased protein intake through balanced nutrition. “Stories should also be kept in muscle”, which is a valuable health bank for elderly patients. Is it better to be thinner? Clearly not, most of the elderly in China suffer from under-ingestion of proteins or from barriers to access, especially on tumours, where many dietary cognitive errors do not guarantee sufficient proteins, and where ingestion of good quality proteins is a prerequisite for maintaining skeletal muscle health. In cases of malnutrition and inadequate food intake among older persons, consideration may be given to the use of nutritional supplements containing milk or animal protein. Reasonable nutritional intake programmes, coupled with effective physical training, can be more effective in countering the effects of muscle scarcity.
After learning about the dangers of myopathy and its negative effects on tumour treatment, let us act together to screen and evaluate older persons, especially those with tumours of the tumours of the tumour, to detect reduction in tumour-related muscle disorders in a timely manner, to provide effective intervention, to improve the quality of life of older patients and to improve the effectiveness of anti-tumour treatment.
Breast cancer
